Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Development of antiinflammatory/analgesic drug discontinued

Nov. 8, 1996

Progress on Scotia's rheumatoid arthritis treatment

Nov. 8, 1996

More convenient formulation of Lodine approved

Nov. 8, 1996

IL-1 receptor antagonists claimed by HMR/Affymax

Nov. 8, 1996

MMP inhibitors described by Procter & Gamble

Nov. 8, 1996

Sandoz reveals SLe(x)-mimetic compounds for treating inflammation

Nov. 8, 1996

Santen reports LTA4 hydrolase inhibitors

Nov. 8, 1996

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

Zenapax enters clinical trials for uveitis

Nov. 1, 1996

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...